TRABECTEDIN for Angiosarcoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 16 adverse event reports in the FDA FAERS database where TRABECTEDIN was used for Angiosarcoma.
Most Reported Side Effects for TRABECTEDIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 207 | 10.6% | 26 | 53 |
| Anaemia | 189 | 9.7% | 22 | 79 |
| Thrombocytopenia | 172 | 8.8% | 20 | 62 |
| Nausea | 160 | 8.2% | 16 | 49 |
| Febrile neutropenia | 142 | 7.3% | 21 | 89 |
| Pancytopenia | 124 | 6.3% | 26 | 74 |
| Vomiting | 121 | 6.2% | 19 | 49 |
| Rhabdomyolysis | 117 | 6.0% | 51 | 80 |
| Off label use | 105 | 5.4% | 29 | 16 |
| Alanine aminotransferase increased | 104 | 5.3% | 13 | 53 |
| Disease progression | 103 | 5.3% | 28 | 15 |
| Acute kidney injury | 92 | 4.7% | 43 | 66 |
| Aspartate aminotransferase increased | 91 | 4.7% | 12 | 49 |
| Asthenia | 90 | 4.6% | 10 | 32 |
| Pyrexia | 89 | 4.6% | 8 | 71 |
Other Indications for TRABECTEDIN
Ovarian cancer (275)
Product used for unknown indication (227)
Soft tissue sarcoma (183)
Leiomyosarcoma (142)
Ovarian cancer recurrent (120)
Uterine leiomyosarcoma (84)
Leiomyosarcoma metastatic (79)
Sarcoma (75)
Myxoid liposarcoma (69)
Liposarcoma (59)
Other Drugs Used for Angiosarcoma
PAZOPANIB (164)
PACLITAXEL (148)
DOXORUBICIN (126)
DOCETAXEL (94)
GEMCITABINE (67)
SIROLIMUS (59)
IFOSFAMIDE (53)
NIVOLUMAB (46)
PEMBROLIZUMAB (37)
BEVACIZUMAB (36)